Results 151 to 160 of about 2,693 (166)
Some of the next articles are maybe not open access.

Summary of opinion: Recarbrio,imipenem / cilastatin / relebactam

Case Medical Research, 2019
openaire   +2 more sources

Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales

Diagnostic Microbiology and Infectious Disease, 2022
Mark Biagi   +2 more
exaly  

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2018
KRISZTINA M Papp-Wallace   +2 more
exaly  

Imipenem monohydrate/cilastatin sodium/relebactam monohydrate, pretomanid, and elexacaftor/tezacaftor/ivacaftor

Journal of the American Pharmacists Association, 2020
Daniel A, Hussar, Elias B, Chahine
openaire   +2 more sources

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2018
Matthew L Rizk   +2 more
exaly  

In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa

Journal of Antimicrobial Chemotherapy, 2020
Maria A Gomis-Font   +2 more
exaly  

Activity of imipenem/relebactam against Pseudomonas aeruginosa with antimicrobial-resistant phenotypes from seven global regions: SMART 2015–2016

Journal of Global Antimicrobial Resistance, 2018
James A Karlowsky   +2 more
exaly  

Effect of Porins and bla KPC Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae : Can Antibiotic Combinations Overcome Resistance?

Microbial Drug Resistance, 2018
David Landman, John Quale
exaly  

In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)

Antimicrobial Agents and Chemotherapy, 2017
Sibylle H Lob   +2 more
exaly  

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

European Journal of Clinical Microbiology and Infectious Diseases, 2019
Irène Galani   +2 more
exaly  
avibactam
imipenem/relebactam
imipenem
vaborbactam
β-lactamase inhibitor
carbapenemase
doripenem
beta-lactamase inhibitors
klebsiella pneumoniae
previous   14  15  16  17  

Home - About - Disclaimer - Privacy